enGenes Biotech to show -excite contribution to sustainable continuous biotech production at BME 2024 in Dublin
top of page
Media Center
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will be an active participant in the latest...
enGenes technologies deliver cost-effective, high-yield bioprocesses over broad range of for specific Applications
enGenes Biotech has developed a suite of patented technology platforms for the customized production of recombinant proteins, enzymes,...
enGenes Biotech Team participates at Vienna City Marathon 2024
Vienna, Austria: As of the Sunday 21st April 2024 has the team of enGenes Biotech, Vienna based Biotech company, participated at the...
enGenes Biotech Launches Its New Website
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) now has a fresh and more comprehensive web...
enGenes Biotech’s continuous microbial protein expression and purification
enGenes Biotech is implementing upgrades to its processes and equipment that will allow it to offer continuous recombinant protein...
enGenes Biotech bringing advanced protein expression offers to Bio-Europe Munich
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will again participate in Europe’s flagship life...
enGenes announce attendance to Recombinant Protein Production (RPP) conference in Girona, Spain
Girona, Spain: – enGenes Biotech GmbH (enGenes) will attend the Recombinant Protein Production (RPP) conference from the 17th – 19th...
enGenes Biotech to make CPHI debut in Barcelona
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will attend Europe’s leading pharma industry...
enGenes to share continuous growth-decoupled production insights at World Biopharm 2023
Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will be a prominent presence as a scientific...
enGenes secure significant funding for ECOnti E. coli Continuous Manufacturing Project
enGenes secure significant funding for ECOnti E. coli Continuous Manufacturing Project News-ReleasesEnGenes Biotech GmbH May 3rd 2023...
bottom of page